Growing use of biologicals for immunologic disease in the US

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 528, 2007-05-19 , pp. 10-10(1)

Publisher: Adis International

Buy & download fulltext article:

OR

Price: $27.95 plus tax (Refund Policy)

Keywords: Abatacept, therapeutic use; Adalimumab, therapeutic use; Etanercept, therapeutic use; Infliximab, therapeutic use; Psoriatic-arthritis, treatment; Rheumatoid-arthritis, treatment; Rituximab, therapeutic use; Tumour-necrosis-factor-antagonists, therapeutic us

Document Type: Short communication

Publication date: 2007-01-01

Related content

In this: publication
By this: publisher
In this Subject: Pharmacology

Sign-in

Register

Marked list

Tools

Get Permissions

Key

Free content

New content

Open Access Content

Open access content

Subscribed Content

Subscribed content

Free Trial Content

Free trial content

Text size:

A | A | A | A

Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon

Print this page

Useful pages

Here are a few pages on the site that we think you may find useful:

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.